Pharmafile Logo
Pharmafocus logo
Advanced Search
cov

MAPs during a global pandemic

February 26, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, MAPS

Early and managed access programmes provide opportunities for patients to get the treatments they need faster – but the COVID-19 …

Feature
top 10

Pharmafile.com’s top 10 news stories of the week

February 26, 2021
Medical Communications news, pharma news, pharmaceuticals, pharmafile, top news stories

COVID-19 news has slowed down in the last week, allowing different pharma developments to take centre stage. In the last …

News
GSK building

GSK’s Phase II otilimab study on COVID-19 patients promising for over-70s

February 26, 2021
Medical Communications COVID-19, GSK, coronavirus, covid-19 treatment, otilimab

GlaxoSmithKline’s (GSK) Phase II OSCAR study of their otilimab antibody’s effect on COVID-19 patients has shown promising results in older …

News

How COVID-19 has changed pharmacovigilance

February 26, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, pharmacovigilance

The race to provide vaccines and treatments for coronavirus has seen a number of COVID-19 drugs reach the market in …

Feature

NICE recommends Novartis’ ribociclib in combination with fulvestrant for breast cancer

February 26, 2021
Medical Communications Cancer, NICE, Novartis

NICE has recommended Novartis’ Kisqali (ribociclib) in combination with fulvestrant for women with prior endocrine therapy. It will be made …

News
merckincweb

MSD acquires Pandion Therapeutics in $1.85bn deal

February 26, 2021
Medical Communications MSD, Pandion

MSD, known as Merck in the United States and Canada, has announced that it will acquire clinical-stage biotechnology company Pandion …

News
takeda_usa_pharmaceuticals_u

Takeda sells four diabetes products to Teijin Pharma for $1.25m

February 26, 2021
Medical Communications Takeda

Takeda has entered into an agreement to transfer the assets, marketing rights, and, eventually, marketing authorisation associated with a portfolio …

News
a vaccination is given

Ghana is first African country to receive COVID-19 vaccines from COVAX

February 25, 2021

The COVAX Facility have delivered their first batch of COVID-19 vaccines to Africa, with 600,000 doses of the Oxford-AstraZeneca vaccine …

News

Xencor and UCLA TDG partner to develop therapeutic antibodies

February 25, 2021
Xencor, ucla

Xencor and UCLA Technology Development Group (UCLA TDG) have announced an agreement to develop novel therapeutic antibodies, pairing novel targets …

News

Newcells Biotech receive £5m to boost liver and lung condition research

February 25, 2021

Stem cell model specialists Newcells Biotech has received £5.25 million in new funding to further their growth in 3D tissue …

News

NICE issues draft guidance recommending sapropterin for PKU in children

February 25, 2021
BioMarin, NICE, PKU

NICE has issued draft guidance which recommends BioMarin’s Kuvan (sapropterin) at a dose of up to 10 mg/kg for treating phenylketonuria …

News

New research article confirms role of masitinib as a potential pancreatic cancer therapy

February 25, 2021
AB Sciences, Cancer, masitinib

A recently published, peer-reviewed research article has concluded that the inhibition of mast cells with AB Science’s masitinib could represent …

News

UC San Diego School of Medicine researchers treat atopic dermatitis with bacteriotherapy

February 24, 2021
Research and Development atopic dermatitis, eczema

Researchers at the University of California San Diego School of Medicine have identified a universal strain of bacteria derived from …

News

Sanofi and SIRION collaborate on AAV vector development to treat serious diseases

February 24, 2021
Research and Development AAV vectors, SIRION, Sanofi

SIRION Biotech and Sanofi have entered into an agreement to develop effective medicines for illnesses impacting major human organs.

News
cervical dysplasia

QIAGEN and INOVIO to develop diagnostic tests for cervical dysplasia treatment

February 24, 2021
Research and Development Inovio, Qiagen, cervical dysplasia

QIAGEN and INOVIO Pharmaceuticals have extended their collaboration to develop a new diagnostic test which identifies the women most likely …

News
bluebird_bio_external_durham_nc_manufacturing

FDA halts studies for bluebird bio’s sickle cell therapy LentiGlobin

February 24, 2021
Research and Development Bluebird Bio, FDA, sickle cell disease

The FDA has put bluebird bio’s LentiGlobin gene therapy programme for sickle cell disease (SCD) on clinical hold, following Suspected …

News
opaganib-bottle-and-tablets

RedHill Biopharma to expand COVID-19 opaganib trial to US

February 24, 2021
Research and Development COVID-19, RedHill Biopharma

RedHill Biopharma has announced its plans to expand the company’s global Phase II/III study of opaganib in patients with severe …

News

Microsoft and UCB collaborate to treat immunological and neurological diseases

February 23, 2021
Manufacturing and Production Microsoft, UCB, artificial intelligence

UCB and Microsoft have agreed a new multi-year collaboration to discover new medicines by combining UCB’s drug discovery and development …

News

Otonomy’s OTIVIDEX ear medicine falls short in Phase III study

February 23, 2021
Manufacturing and Production meniere's disease, otividex, otonomy

Otonomy’s OTIVIDEX treatment for Meniere’s disease has failed to meet its primary endpoint in its Phase III trial, the company …

News

Novo Holdings acquires pharma research company Altasciences

February 23, 2021
Manufacturing and Production Novo Holdings, altasciences, pharma research

Novo Holdings has agreed a deal to buy Canadian pharmaceutical research company Altasciences from Audax Private Equity, the two companies …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025